With a revenue increase of 23.06% in the second quarter 2026, year on year to cumulative value of $251 million, Axogen Inc 's revenue per employee grew on a trailing twelve months basis to $ 403,817, this marks a new company high. Within the Healthcare sector Employees of 252 other companies have achieved higher revenue per employee. While Axogen Inc 's total ranking has deteriorated compared to the previous quarter from 1366 to 2023. Axogen Inc has 622 employees.
IntroductionAxogen Inc. a prominent player in surgical solutions for peripheral nerve injuries, has made significant strides despite facing various challenges. The recent appointment of Craig Swandal, an experienced executive in medical device manufacturing, as the new Vice President of Operations marks a strategic move for the company s leadership team. Coupled with a reported revenue increase and employee growth metrics, these developments reflect Axogen s strategic initiatives to enhance its business while grappling with financial setbacks.Fact 1: New Leadership and Inducement GrantOn July 1, 2024, Axogen announced an inducement grant under NASDAQ listing rule 5635(c)(4) to attract a new non-executive employee. This strategic decision underscores the company s commitment to enhancing its operational capabilities in the competitive healthcare sector. By incentivizing highly qualified non-executive professionals, Axogen aims to bolster its innovative capacity in peripheral nerve injury solutions.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
